KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Raw Materials: 2013-2025

Historic Raw Materials for CareDx (CDNA) over the last 12 years, with Sep 2025 value amounting to $13.7 million.

  • CareDx's Raw Materials rose 41.89% to $13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year increase of 41.89%. This contributed to the annual value of $10.9 million for FY2024, which is 2.53% up from last year.
  • Per CareDx's latest filing, its Raw Materials stood at $13.7 million for Q3 2025, which was down 1.52% from $13.9 million recorded in Q2 2025.
  • CareDx's 5-year Raw Materials high stood at $13.9 million for Q2 2025, and its period low was $8.1 million during Q1 2021.
  • Its 3-year average for Raw Materials is $11.2 million, with a median of $10.5 million in 2024.
  • Per our database at Business Quant, CareDx's Raw Materials spiked by 364.53% in 2021 and then dropped by 14.41% in 2023.
  • Over the past 5 years, CareDx's Raw Materials (Quarterly) stood at $10.4 million in 2021, then increased by 14.52% to $12.0 million in 2022, then fell by 11.22% to $10.6 million in 2023, then climbed by 2.53% to $10.9 million in 2024, then soared by 41.89% to $13.7 million in 2025.
  • Its last three reported values are $13.7 million in Q3 2025, $13.9 million for Q2 2025, and $13.7 million during Q1 2025.